http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-046645-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-64
filingDate 2004-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f703cf1530038e486f5e239eda38545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c6b8fac0a295d4befe6c56a7ea6dfa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6643ee6c658d3ad00b174ec6d29890c
publicationDate 2005-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-046645-A1
titleOfInvention BENZOFURANS AND BENZOTIOPHENS, PREPARATION PROCEDURE AND USES
abstract This refers to compounds of the general formula (1), wherein: X = O or S; R1 is selected from: -Alk-COOH; -Alk-C (= O) - (O) m-Ar; -Alk-C (= O) - (O) m-Het; -Alk-C (= O) - (O) m-Alk; -Alk-C (= O) - (O) m-cycloalkyl; -Alk-C (= O) NRR '; -Alk- (O) m-Ar; -Alk-O-Alk; -Alk-O-Alk-Ar; -Alk-O-Het; R2 is selected from -Alk, -Ar and -cycloalkyl; R3, R4, R5, and R6, which may be identical or different, are independently selected from H, -Hal, -OH, -Alk, -OAlk, -CN, -CF3, -NRR 'and -NO2 ; where, in the definitions of R1-R6: each of Alk, which may be identical or different, is optionally and independently substituted with one or more groups selected from -Hal, -OAlk, -Ar, -OAlkAr, -OH, -CN, -OAr, -CF3, -COOH, -NRR ', -C (= O) - (O) mAlk, -Het and -NO2; each of Ar, which may be identical or different, is optionally and independently substituted with one or more groups selected from -Hal, -OAlk, -Alk, -Ar, OAlkAr, -OH, -CN, -OAr, -CF3, -AlkAr, -COOH, -C (= O) - (O) mAlk, -Alk-C (= O) - (O) m-Alk, -NRR ', -Het and -NO2, -S (O) nAr and -S (O) nAlk; R and R 'are independently selected from H and Alk; m = 0 or 1; and also its stereoisomers, their racemates and pharmaceutically acceptable salts, except for the compounds for which: R1 = -CH2-C (= O) Me; R2 = -Me; X = O; R3, R5 = H and each R4, R6 = H or OMe. These compounds can be used in the treatment of pathologies associated with insulin resistance syndrome.
priorityDate 2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365

Total number of triples: 28.